{
    "id": "403",
    "title": "UCSF-CAPRA Score for Prostate Cancer Risk",
    "desc": "The UCSF-CAPRA (Cancer of the Prostate Risk Assessment) Score predicts outcomes of patients post-treatment for prostate cancer.",
    "data": {
        "orgreference": [
            {
                "href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697208/",
                "text": "Cooperberg MR, Broering JM, Carroll PR. Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis. JNCI Journal of the National Cancer Institute. 2009;101(12):878-887. doi:10.1093/jnci/djp122."
            }
        ],
        "other_refer": [
            {
                "href": "",
                "text": ""
            }
        ],
        "evidence": "<p>Addition of the selected points.</p>",
        "facts": "<p><strong>Score interpretation:</strong></p>\n<div class=\"table-responsive\">\n<table class=\"table table-bordered table-hover\">\n<tbody>\n<tr>\n<th></th>\n<th colspan=\"2\">Metastasis-free interval <br>% likelihood (95% CI)</th>\n<th colspan=\"2\">Prostate cancer&ndash;specific survival <br>% likelihood (95% CI)</th>\n<th colspan=\"2\">Overall survival <br>% likelihood (95% CI)</th>\n</tr>\n<tr>\n<td><strong>CAPRA Risk Group</strong></td>\n<td><strong>5-year</strong></td>\n<td><strong>10-year</strong></td>\n<td><strong>5-year</strong></td>\n<td><strong>10-year</strong></td>\n<td><strong>5-year</strong></td>\n<td><strong>10-year</strong></td>\n</tr>\n<tr>\n<td>Low Risk Group (0-2 points)</td>\n<td>99.3 (98.8 to 99.5)</td>\n<td>97.5 (95.9 to 98.5)</td>\n<td>99.7 (99.9 to 99.5)</td>\n<td>97.1 (98.2 to 95.1)</td>\n<td>92.5 (91.5 to 93.5)</td>\n<td>71.4 (67.8 to 74.7)</td>\n</tr>\n<tr>\n<td>Intermediate Risk Group (3-5 points)</td>\n<td>96.9 (96.2 to 97.5)</td>\n<td>93.3 (91.7 to 94.6)</td>\n<td>98.6 (99.0 to 98.1)</td>\n<td>91.6 (93.4 to 89.5)</td>\n<td>90.2 (89.0 to 91.3)</td>\n<td>59.7 (56.7 to 62.7)</td>\n</tr>\n<tr>\n<td>High Risk Group (&ge;6 points)</td>\n<td>90.4 (88.4 to 92.0)</td>\n<td>83.4 (79.6 to 86.6)</td>\n<td>93.4 (94.9 to 91.5)</td>\n<td>79.1 (83.1 to 74.3)</td>\n<td>78.7 (75.9 to 81.2)</td>\n<td>42.0 (37.4 to 46.5)</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p>For more detailed risk outcomes, see <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697208/\" target=\"_blank\" rel=\"noopener\">Cooperberg 2009</a>.</p>",
        "estimation": [],
        "primary_complains": [
            "Weight Loss/Gain"
        ],
        "disease_treated": [
            "Cancer"
        ],
        "logic": "var calc_output = [];\nvar msg = '';\nvar mini_msg = '';\nvar grade = '';\nvar v = parseInt(age) + parseInt(psa) + parseInt(gleason) + parseInt(stage) + parseInt(biopsy);\nif (v < 3) { msg = 'Low risk by UCSF-CAPRA.';\n    mini_msg = 'Low risk' }\nif (v > 2 && v < 6) { msg = 'Intermediate risk by UCSF-CAPRA.';\n    mini_msg = 'Intermediate risk' }\nif (v > 5) { msg = 'High risk by UCSF-CAPRA.';\n    mini_msg = 'High risk' }\nif (v == 0 || v == 1) { grade = '~85% disease-free survival at 5 years.'; }\nif (v == 2) { grade = '75-81% disease-free survival at 5 years.'; }\nif (v == 3) { grade = '~66% disease-free survival at 5 years.'; }\nif (v == 4) { grade = '~61% disease-free survival at 5 years.'; }\nif (v == 5) { grade = '52-60% disease-free survival at 5 years.'; }\nif (v == 6) { grade = '29-34% disease-free survival at 5 years.'; }\nif (v > 6) { grade = '8-20% disease-free survival at 5 years.'; }\ncalc_output.push({ \n    name: 'mini', \n    value: v, \n    value_text: 'points', \n    message: mini_msg \n});\ncalc_output.push({ \n    name: '2046_UCSF-CAPRA Score_result', \n    value: v, \n    value_text: 'points', \n    message: msg + ' ' + grade \n});",
        "inputs": [
            {
                "conditionality": "",
                "default": 0,
                "label_en": "Age",
                "mdcalc_info_concept": null,
                "name": "age",
                "option_fhir_rules": null,
                "optional": false,
                "options": [
                    {
                        "label": "< 50 years",
                        "value": 0
                    },
                    {
                        "label": "≥ 50 years",
                        "value": 1
                    }
                ],
                "show_points": true,
                "tips_en": "",
                "type": "radio"
            },
            {
                "conditionality": "",
                "default": 0,
                "label_en": "PSA at diagnosis (ng/mL)",
                "mdcalc_info_concept": null,
                "name": "psa",
                "option_fhir_rules": null,
                "optional": false,
                "options": [
                    {
                        "label": "<6",
                        "value": 0
                    },
                    {
                        "label": "≥6 - 10",
                        "value": 1
                    },
                    {
                        "label": "≥10 - 20",
                        "value": 2
                    },
                    {
                        "label": "≥20 - 30",
                        "value": 3
                    },
                    {
                        "label": ">30",
                        "value": 4
                    }
                ],
                "show_points": true,
                "tips_en": "",
                "type": "radio"
            },
            {
                "conditionality": "",
                "default": 0,
                "label_en": "Gleason Score pattern (primary or secondary)",
                "mdcalc_info_concept": null,
                "name": "gleason",
                "option_fhir_rules": null,
                "optional": false,
                "options": [
                    {
                        "label": "No 4 or 5 pattern present",
                        "value": 0
                    },
                    {
                        "label": "4 or 5 pattern in secondary",
                        "value": 1
                    },
                    {
                        "label": "4 or 5 pattern in primary",
                        "value": 3
                    }
                ],
                "show_points": true,
                "tips_en": "",
                "type": "radio"
            },
            {
                "conditionality": "",
                "default": 0,
                "label_en": "Clinical stage",
                "mdcalc_info_concept": null,
                "name": "stage",
                "option_fhir_rules": null,
                "optional": false,
                "options": [
                    {
                        "label": "T1 or T2",
                        "value": 0
                    },
                    {
                        "label": "T3a",
                        "value": 1
                    }
                ],
                "show_points": true,
                "tips_en": "",
                "type": "radio"
            },
            {
                "conditionality": "",
                "default": 0,
                "label_en": "Percent biopsy cores positive for cancer",
                "mdcalc_info_concept": null,
                "name": "biopsy",
                "option_fhir_rules": null,
                "optional": false,
                "options": [
                    {
                        "label": "<34%",
                        "value": 0
                    },
                    {
                        "label": "≥34%",
                        "value": 1
                    }
                ],
                "show_points": true,
                "tips_en": "",
                "type": "radio"
            }
        ],
        "can_search": [
            "prostate CA",
            "CA"
        ],
        "specialty": [
            "Hematology and Oncology",
            "Urology"
        ]
    }
}